Hepatocellular Carcinomas Clinical Trial
Official title:
Multipolar Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma Using Classical Intranodular Technique Versus Extra Nodular Technique So-called "No Touch" Technique: A Prospective Randomized Trial
The primary purpose of the trial is to demonstrate that at least a 40% drop of recurrence rate can be achieve in hepatocellular carcinoma patients treated with no touch multipolar radiofrequency ablation technique compared to those treated with usual intranodular multipolar technique.
206 patients with hepatocellular carcinoma(s) including up to three nodules measuring up to
four cm in diameter, will be randomized in two therapeutic legs: multipolar no touch
radiofrequency versus multipolar intra nodular radiofrequency. Patients previously treated
for hepatocellular carcinoma will not be enrolled in the study. Diagnostic of hepatocellular
carcinoma will be based on American Society of Liver Diseases guide line. Early response to
the treatment will be assessed one month after the radiofrequency ablation procedures (up to
three in case of incomplete necrosis) with dynamic contrast medium enhanced CT or MRI liver
examinations. For the follow up dynamic contrast medium enhanced CT or MRI liver examinations
will be performed every three months.
The trial will last for 73 months including 45 months for the recruitment of patients. The
main criteria of judgement will be the 2-years recurrence rate.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01126463 -
188RE-SSS Lipiodol to Treat HepatoCellular Carcinomas
|
Phase 1 | |
| Completed |
NCT01641276 -
Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
|
N/A |